Encompass Health Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US29261A1007
USD
113.02
-0.02 (-0.02%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
5,373.20
4,801.20
4,348.60
4,014.90
4,644.40
4,605.00
4,277.30
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
5,373.20
4,801.20
4,348.60
4,014.90
4,644.40
4,605.00
4,277.30
Raw Material Cost
4,299.50
3,867.70
3,564.10
3,186.00
3,841.10
3,665.50
3,375.50
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
2,901.00
2,600.10
2,425.00
2,160.10
2,711.50
2,573.00
2,373.80
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
137.40
143.50
175.70
164.30
184.20
159.70
147.30
Selling and Distribution Expenses
209.20
201.70
154.30
169.50
155.50
247.00
220.20
Other Expenses
-303.84
-274.36
-260.07
-232.44
-289.57
-273.27
-252.11
Total Expenditure (Excl Depreciation)
4,508.70
4,069.40
3,718.40
3,355.50
3,996.60
3,912.50
3,595.70
Operating Profit (PBDIT) excl Other Income
864.5
731.8000000000001
630.2
659.4
647.8
692.5
681.5999999999999
Other Income
23.10
18.90
5.10
10.30
13.70
18.00
10.90
Operating Profit (PBDIT)
1,187.20
1,024.60
878.90
889.30
904.50
929.20
892.20
Interest
137.40
143.50
175.70
164.30
184.20
159.70
147.30
Exceptional Items
-0.60
0.00
-8.80
-0.40
-4.70
11.50
-52.00
Gross Profit (PBDT)
1,073.70
933.50
784.50
828.90
803.30
939.50
901.80
Depreciation
299.60
273.90
243.60
219.60
243.00
218.70
199.70
Profit Before Tax
749.60
607.20
450.80
505.00
472.60
562.30
493.20
Tax
150.20
132.20
100.10
101.90
103.80
115.90
118.90
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
455.70
361.60
256.00
298.80
283.20
358.00
290.30
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
455.70
361.60
256.00
298.80
283.20
358.00
290.30
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
140.90
111.00
93.60
103.20
84.60
87.10
83.10
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
596.60
472.60
349.60
402.00
367.80
445.10
373.40
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
2,067.00
1,647.50
1,310.30
1,911.30
1,588.00
1,352.20
1,276.70
Earnings per share (EPS)
4.46
3.47
2.7
4.11
2.85
3.61
2.93
Diluted Earnings per share
4.46
3.47
2.7
4.11
2.85
3.61
2.93
Operating Profit Margin (Excl OI)
16.09%
15.24%
14.49%
16.42%
13.95%
15.04%
15.94%
Gross Profit Margin
19.53%
18.35%
15.97%
18.05%
15.41%
16.96%
16.2%
PAT Margin
8.48%
7.53%
5.89%
7.44%
6.1%
7.77%
6.79%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 11.91% vs 10.41% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 26.24% vs 35.18% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 15.75% vs 15.09% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -4.25% vs -18.33% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Encompass Health Corp. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
5,373.20
6,060.53
-687.33
-11.34%
Other Operating Income
0.00
0.00
0.00
Total Operating income
5,373.20
6,060.53
-687.33
-11.34%
Raw Material Cost
4,299.50
6,080.15
-1,780.65
-29.29%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
2,901.00
0.00
2,901.00
Power Cost
0
0
0.00
Manufacturing Expenses
137.40
6.18
131.22
2,123.30%
Selling and Distribution Expenses
209.20
264.33
-55.13
-20.86%
Other Expenses
-303.84
-0.62
-303.22
-48,906.45%
Total Expenditure (Excl Depreciation)
4,508.70
6,344.49
-1,835.79
-28.94%
Operating Profit (PBDIT) excl Other Income
864.50
-283.96
1,148.46
404.44%
Other Income
23.10
49.48
-26.38
-53.31%
Operating Profit (PBDIT)
1,187.20
-210.01
1,397.21
665.31%
Interest
137.40
6.18
131.22
2,123.30%
Exceptional Items
-0.60
-8.17
7.57
92.66%
Gross Profit (PBDT)
1,073.70
-19.62
1,093.32
5,572.48%
Depreciation
299.60
24.46
275.14
1,124.86%
Profit Before Tax
749.60
-248.83
998.43
401.25%
Tax
150.20
1.45
148.75
10,258.62%
Provisions and contingencies
0
0
0.00
Profit After Tax
455.70
-250.33
706.03
282.04%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
455.70
-250.33
706.03
282.04%
Share in Profit of Associates
0
0
0.00
Minority Interest
140.90
0.05
140.85
281,700.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
596.60
-250.28
846.88
338.37%
Equity Capital
0
0
0.00
Face Value
0.01
0.01
0.00
Reserves
2,067.00
470.95
1,596.05
338.90%
Earnings per share (EPS)
4.46
-0.61
5.07
831.15%
Diluted Earnings per share
4.46
-0.61
5.07
831.15%
Operating Profit Margin (Excl OI)
16.09%
-4.69%
0.00
20.78%
Gross Profit Margin
19.53%
-3.70%
0.00
23.23%
PAT Margin
8.48%
-4.13%
0.00
12.61%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 537.32 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 11.91% vs 10.41% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 59.66 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 26.24% vs 35.18% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 116.41 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 15.75% vs 15.09% in Dec 2023

Annual - Interest
Interest 13.74 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -4.25% vs -18.33% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.09%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023